WC
IDXX icon

Waterloo Capital’s Idexx Laboratories IDXX Stock Holding History

Waterloo Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Buy
392
+44
+13% +$28.2K 0.02% 453
2025
Q4 		$235K Sell
348
-10
-3% -$6.81K 0.02% 422
2025
Q3 		$229K Sell
358
-84
-19% -$51K 0.02% 415
2025
Q2 		$237K Buy
+442
New +$211K 0.02% 408

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Waterloo Capital's IDXX Position: Q1 2026 in Review

Waterloo Capital increased its Idexx Laboratories (IDXX) stake by 13% in Q1 2026, buying an estimated $28.2K and bringing the position to 392 shares worth $220K. The position accounts for 0.02% of the portfolio, ranked #453.

Waterloo Capital first reported a position in IDXX in Q2 2025 and has held it in 4 quarters since. The position peaked at $237K in Q2 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Waterloo Capital held 392 shares of Idexx Laboratories worth $220K as of Q1 2026.
  • Waterloo Capital bought 44 Idexx Laboratories shares in Q1 2026, an estimated $28.2K.
  • Idexx Laboratories made up 0.02% of Waterloo Capital's portfolio in Q1 2026, its #453 holding.
  • Waterloo Capital first reported a position in Idexx Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Waterloo Capital's Idexx Laboratories position peaked at $237K in Q2 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.